Changing Patterns of Anemia Management in US Hemodialysis Patients
Authors:
- Janet K. FreburgerJFJanet K. Freburger
- Leslie J. NgLNLeslie J. Ng
- Brian D. BradburyBBBrian D. Bradbury
- Abhijit V. KshirsagarAKAbhijit V. Kshirsagar
- M. Alan BrookhartMBM. Alan Brookhart
- 1 September 2012
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 125 (9) , 906-914.e9
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Are there implications from the Trial to Reduce Cardiovascular Events with Aranesp Therapy study for anemia management in dialysis patients?Current Opinion in Nephrology and Hypertension, 2010
- Iron supplementation to treat anemia in patients with chronic kidney diseaseNature Reviews Nephrology, 2010
- Changes in erythropoiesis-stimulating agent (ESA) dosing and haemoglobin levels in US non-dialysis chronic kidney disease patients between 2005 and 2009Nephrology Dialysis Transplantation, 2010
- Parenteral Iron UseClinical Journal of the American Society of Nephrology, 2009
- Ferric Gluconate Reduces Epoetin Requirements in Hemodialysis Patients with Elevated FerritinJournal of the American Society of Nephrology, 2008
- Predictors of the response to treatment in anemic hemodialysis patients with high serum ferritin and low transferrin saturationKidney International, 2007
- Ferric Gluconate Is Highly Efficacious in Anemic Hemodialysis Patients with High Serum Ferritin and Low Transferrin SaturationJournal of the American Society of Nephrology, 2007
- Correction of Anemia with Epoetin Alfa in Chronic Kidney DiseaseNew England Journal of Medicine, 2006
- HEMATOLOGY: ISSUES IN THE DIALYSIS PATIENT: Intravenous Iron Therapy in End‐Stage Renal DiseaseSeminars in Dialysis, 2006
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987